BRONCHIAL ASTHMA
Clinical trials for BRONCHIAL ASTHMA explained in plain language.
Never miss a new study
Get alerted when new BRONCHIAL ASTHMA trials appear
Sign up with your email to follow new studies for BRONCHIAL ASTHMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Home workouts prescribed to fight heart and lung disease
Disease control Recruiting nowThis study is testing whether an 8-week exercise program done at home or in the community can improve fitness and quality of life for adults with reduced heart or lung function. Researchers will compare 200 participants who do the exercise program to those who do not. The program…
Matched conditions: BRONCHIAL ASTHMA
Phase: NA • Sponsor: Guangdong Provincial People's Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
AI app aims to fix a major problem for millions with lung disease
Disease control Recruiting nowThis study aims to help people with COPD and asthma stick to their inhaled medication plans. Researchers will test a new mobile app and training program designed to teach both patients and their healthcare providers the correct way to use inhalers. The goal is to improve treatmen…
Matched conditions: BRONCHIAL ASTHMA
Phase: NA • Sponsor: Charles University, Czech Republic • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New inhaler aims to help control asthma breathing
Disease control Recruiting nowThis study is testing a new inhaled steroid medication called PA9159 for adults with asthma. It will compare the new inhaler to a commonly used steroid inhaler to see if it is safe and helps improve breathing. About 30 participants will use one of the inhalers for 4 weeks while r…
Matched conditions: BRONCHIAL ASTHMA
Phase: PHASE2 • Sponsor: Anhui Palo Alto Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New inhaler aims to help adults breathe easier
Disease control Recruiting nowThis study is testing a new inhaled steroid medication called PA9159 to see if it is safe and effective for controlling asthma in adults. About 60 participants with asthma will use either the new inhaler at different doses or a placebo inhaler for 4 weeks. Researchers will measur…
Matched conditions: BRONCHIAL ASTHMA
Phase: PHASE2 • Sponsor: Anhui Palo Alto Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Asthma drug for kids under the microscope in new safety study
Disease control Recruiting nowThis study aims to monitor the safety and effectiveness of the asthma medication FASENRA in children aged 6 to 15 years. It will observe about 40 children with severe asthma who are starting FASENRA for the first time in real-world, everyday use. The main goal is to check for any…
Matched conditions: BRONCHIAL ASTHMA
Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC
-
Scientists hunt for disease clues in your breath
Knowledge-focused Recruiting nowThis study aims to find out if a simple, non-invasive breath test can help doctors better monitor lung inflammation and infections in people with asthma or cystic fibrosis. Researchers will collect and analyze the tiny droplets in exhaled breath from 450 participants, including p…
Matched conditions: BRONCHIAL ASTHMA
Sponsor: The Institute of Molecular and Translational Medicine, Czech Republic • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:28 UTC